Innovator Filgrastim versus Generic Filgrastim in Hematopoietic Stem Cell Transplantation Mobilization

Methods This is a retrospective study. G-CSF was administered in the dose of 10 μg/kg subcutaneous as a single dose for 4 days. On day 5, peripheral blood stem cell (PBSC) apheresis was performed using Haemonetics MCS plus or COBE Spectra apheresis machine through a double-lumen central venous cathe...

Descripción completa

Detalles Bibliográficos
Autores principales: Husian, Sadik, Jeyaraman, Preethi, Gupta, S. K., Rai, Reeta, Pathak, Sangeeta, Dayal, Nitin, Naithani, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687862/
https://www.ncbi.nlm.nih.gov/pubmed/34938680
http://dx.doi.org/10.1055/s-0041-1729446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687862/
https://www.ncbi.nlm.nih.gov/pubmed/34938680
http://dx.doi.org/10.1055/s-0041-1729446

Ejemplares similares